Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134114) titled 'Single-Arm, Multicenter, Phase II Exploratory Clinical Study of Paclitaxel Polymer Micelles for Injection Combined with Bevacizumab in the Treatment of Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer' on Oct. 10.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Sun Yat-sen University Cancer Center

Condition: Recurrent ovarian cancer

Intervention: 1:Paclitaxel Polymer Micelles for Injection Combined with Bevacizumab for Once-Weekly Therapy

Recruitment Status: Recruiting

Phase: 2

Date of First Enrollment: 2024-12-31 ...